A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance.

Thomas R Arkell Brooke Manning Luke A Downey Amie C Hayley

Published in: CNS drugs (2023)

These findings suggest that prescribed medical cannabis may have minimal acute impact on cognitive function among patients with chronic health conditions, although larger and controlled trials are needed.

Keyphrases

healthcare
open label
phase iii
phase ii
clinical trial
study protocol
liver failure
public health
mental health
bipolar disorder
randomized controlled trial
respiratory failure
squamous cell carcinoma
drug induced
phase ii study
radiation therapy
risk assessment
hepatitis b virus
social media